Chatsworth, CA-- Renaissance Herbs, Inc. will introduce significant new delivery modalities and innovative uses for HCA under an exclusive licensing agreement with Glykon Technologies Group, LLC.
This agreement incorporates 13 United States patents and patents pending plus additional proprietary technology. Glykon Technologies Group discovered and holds the rights to make claims regarding the impact of HCA on the regulation of insulin and blood sugar (Syndrome X), modulation of leptin and glucocorticoids, improvements in bone mineralization, the regulation of immune function, and inflammation. The company also has patented multiple technologies greatly expanding the range of available delivery forms for HCA as well as improving its assimilation and activity. Now, for the first time, full-scale use of the more biologically active calcium-free salts is commercially feasible. Renaissance Herbs was chosen as a partner because of the company’s history as a major supplier of superior grade HCA, its new GMP production facilities, its proven commitment to maintaining the highest standards in the industry and its recent awards for environmental awareness.
Renaissance Herbs, Inc. (www.renaissanceherbs.com ) is a company dedicated to the research and development of the finest and most innovative botanical health care products available today. The company was founded in 1990 by Alex Moffett and maintains offices in Chatsworth, California; Bangalore, India; and Bangkok Thailand.
Glykon Technologies Group specializes in research, intellectual property development and licensing and is based in Las Vegas, Nevada.